Lycia's $318M IPO; Merck sac-TMT trial stopped early
Plus news about Hexagon Bio, Mineralys Therapeutics and Arbor Biotechnologies. Lycia prices $317.5 million IPO: Lycia Therapeutics, a company founded by Nobel Prize winner Carolyn Bertozzi, is pricing its initial public ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.